Hubert C Chen
CIK 1622297 · Chief Medical Officer · last filed 2026-06-03
Hubert C Chen is a Chief Medical Officer who has filed 15 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for VKTX, was dated Jun 3, 2026. Across all open-market trades the lifetime net is +$11.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.69M
4
15
$11.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VKTX | Chief Medical Officer | — | $28.75 | — | $0 | 1 | 2026-06-03 |
| FBRX | See remarks | 96,478 | $17.56 | $1.69M | $0 | 7 | 2024-01-03 |
| Metacrine, Inc. (MTCR) Delisted | Chief Medical Officer | 3,289 | $0.49 | $1.6K | $11.8K | 2 | 2021-05-20 |
| Pfenex Inc. (PFNX) Delisted | See Remarks | — | — | — | $0 | 5 | 2018-02-02 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | VKTX | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | FBRX | Mixed | +4,427 | -$2.5K | EDGAR |
| 2023-10-03 | FBRX | Mixed | +4,907 | -$1.7K | EDGAR |
| 2023-08-02 | FBRX | Grant (A) | +74,257 | $75.0K | EDGAR |
| 2023-07-05 | FBRX | Mixed | +4,907 | -$2.7K | EDGAR |
| 2023-04-04 | FBRX | Mixed | +4,907 | -$2.6K | EDGAR |
| 2023-02-27 | FBRX | Grant (A) | — | $0 | EDGAR |
| 2022-06-08 | FBRX | Grant (A) | — | $0 | EDGAR |
| 2021-05-20 | Metacrine, Inc. (MTCR) Delisted | Buy (P) | +3,289 | $11.8K | EDGAR |
| 2021-02-12 | Metacrine, Inc. (MTCR) Delisted | Grant (A) | — | $0 | EDGAR |